CCM
Camber Capital Management’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-400,000
| Closed | -$86.3M | – | 36 |
|
2024
Q1 | $86.3M | Buy |
+400,000
| New | +$86.3M | 2.11% | 15 |
|
2022
Q4 | – | Sell |
-200,000
| Closed | -$53.4M | – | 39 |
|
2022
Q3 | $53.4M | Buy |
200,000
+75,000
| +60% | +$20M | 1.64% | 20 |
|
2022
Q2 | $25.5M | Buy |
+125,000
| New | +$25.5M | 1.11% | 23 |
|
2022
Q1 | – | Sell |
-250,000
| Closed | -$60M | – | 39 |
|
2021
Q4 | $60M | Buy |
250,000
+175,000
| +233% | +$42M | 2.06% | 19 |
|
2021
Q3 | $21.2M | Buy |
+75,000
| New | +$21.2M | 0.65% | 30 |
|
2021
Q1 | – | Sell |
-200,000
| Closed | -$49M | – | 35 |
|
2020
Q4 | $49M | Buy |
+200,000
| New | +$49M | 1.72% | 16 |
|
2020
Q2 | – | Sell |
-200,000
| Closed | -$63.3M | – | 32 |
|
2020
Q1 | $63.3M | Sell |
200,000
-150,000
| -43% | -$47.5M | 3.78% | 12 |
|
2019
Q4 | $104M | Hold |
350,000
| – | – | 5.29% | 3 |
|
2019
Q3 | $81.5M | Buy |
+350,000
| New | +$81.5M | 4.29% | 7 |
|
2019
Q2 | – | Sell |
-400,000
| Closed | -$94.6M | – | 29 |
|
2019
Q1 | $94.6M | Buy |
400,000
+150,000
| +60% | +$35.5M | 4.71% | 5 |
|
2018
Q4 | $75.2M | Sell |
250,000
-50,000
| -17% | -$15M | 3.57% | 10 |
|
2018
Q3 | $106M | Sell |
300,000
-150,000
| -33% | -$53M | 4.54% | 6 |
|
2018
Q2 | $131M | Sell |
450,000
-65,000
| -13% | -$18.9M | 5.03% | 3 |
|
2018
Q1 | $141M | Buy |
+515,000
| New | +$141M | 6.92% | 4 |
|
2017
Q3 | – | Sell |
-100,000
| Closed | -$27.1M | – | 23 |
|
2017
Q2 | $27.1M | Buy |
+100,000
| New | +$27.1M | 1.32% | 19 |
|
2017
Q1 | – | Sell |
-175,000
| Closed | -$49.6M | – | 32 |
|
2016
Q4 | $49.6M | Buy |
+175,000
| New | +$49.6M | 2.58% | 17 |
|
2016
Q3 | – | Sell |
-275,000
| Closed | -$66.5M | – | 34 |
|
2016
Q2 | $66.5M | Buy |
275,000
+100,000
| +57% | +$24.2M | 3.21% | 6 |
|
2016
Q1 | $45.6M | Buy |
+175,000
| New | +$45.6M | 2.67% | 15 |
|